Caffeine does not potentiate γ-radiation induced DNA damage in ataxia telangiectasia lymphoblastoid cells

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 401, Issue 1-2, 1998, Pages 27-32

  Bebb, D Gwyn ^a,b,c   Steele, Patricia P ^a   Warrington, Pamela J ^a   Moffat, Joyce A ^a   Glickman, Barry W ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

^b BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Ataxia telangiectasia; Caffeine; Chromatid breaks; Ionizing radiation

Indexed keywords

CAFFEINE; DNA;

ANIMAL CELL; ARTICLE; ATAXIA TELANGIECTASIA; AUTOSOMAL RECESSIVE DISORDER; CHO CELL; CHROMATID ABERRATION; CHROMOSOME 11Q; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; GAMMA RADIATION; HETEROZYGOTE; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; NONHUMAN; PRIORITY JOURNAL;

ATAXIA TELANGIECTASIA; CAFFEINE; CELL LINE; DNA; DNA DAMAGE; DNA REPAIR; FEMALE; GAMMA RAYS; HETEROZYGOTE; HUMANS; KINETICS; LYMPHOCYTES; MALE; MICRONUCLEUS TESTS;

ANIMALIA; ATAXIA; ATAXIA TELANGIECTASIA;

EID: 0032486110     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(97)00214-5     Document Type: Article

References (42)

1. O. Jelmert, I.L. Hansteen, S. Langard, Enhanced cytogenetic detection of previous in vivo exposure to mutagens in human lymphocytes after treatment with inhibitors of DNA synthesis and DNA repair in vitro, Mutation Res. 271 (1992) 289-298.
2. T.T. Puck, H. Morse, R. Johnson, C.A. Waldren, Caffeine enhanced measurements of mutagenesis by low levels of γ-irradiation in human lymphocytes, Somatic Cell Mol. Genet. 19 (5) (1993) 423-429.
3. I.G. Walker, B.D. Reid, Caffeine potentiation of the lethal action of alkylating agents on L cells, Mutation Res. 12 (1971) 101-104.
4. C.P. Selby, A. Sancer, Molecular mechanisms of DNA inhibition by caffeine, Proc. Natl. Acad. Sci. USA 87 (1990) 3522-3525.
5. P.M. Busse, S.K. Bose, R.W. Jones, L.J. Tlmach, The action of caffeine on X-irradiated HeLA cells: II. Synergistic lethality, Radiat. Res. 71 (1977) 666-667.
6. 2 /M-phase arrest and release in ataxia telangiectasia and normal cells after exposure to ionizing radiation, Radiat. Res. 140 (1994) 17-23.
7. J.P. Murnane, Cell cycle regulation in response to DNA damage in mammalian cells: a historical perspective, Cancer Metastasis Rev. 14 (1995) 17-29.
8. R.A. Gatti, E. Boder, H.V. Vinters, R.S. Sparkes, A. Norman, K. Lange, Ataxia telangiectasia: an interdisciplinary approach to pathogenesis, Medicine 70 (2) (1991) 99-117.
9. M.C. Paterson, A.K. Anderson, B.P. Smith, P.J. Smith, Enhanced radiosensitivity of cultured fibroblasts from ataxia telangiectasia heterozygotes manifested by defective colony-forming ability and reduced DNA repair replication after hypoxic γ-irradiation, Cancer Res. 39 (1979) 3725-3734.
10. 2 phase delay and chromatid damage in families with ataxia telangiectasia, Cancer Genet. Cytogenet. 76 (1994) 43-46.
11. G.W. Birrell, J.R. Ramsey, Induction of p53 protein by gamma radiation in lymphocyte lines from breast cancer and ataxia telangiectasia patients, Br. J. Cancer 72 (1995) 1096-1101.
12. E. Duchaud, A. Ridet, Y. Delic, E. Cunardi, E. Moustacchi, F. Rosselli, Changes in the radiation induced apoptotic response in homozygotes and heterozygotes for the ataxia telangiectasia gene, C. R. Acad. Sci. 317 (1994) 983-989.
13. 2 phase delay in radiosensitive body cells from non-Hodgkin's lymphoma patients: an indication of cell cycle defects, Mutation Res. 311 (1994) 265-276.
14. T.K. Pandita, W.N. Hittelman, Increased initial levels of chromosome damage and heterogeneous chromosome repair in ataxia telangiectasia heterozygote cells, Mutation Res. 310 (1994) 1-13.
15. K. Savitsky, A. Bar-Shira, S. Gilad, G. Rotman, Y. Ziv, L. Vanagaite, D.A. Tagle, S. Smith, T. Uziel, S. Sfez, M. Ashkenazi, I. Pecker, M. Frydman, R. Harnik, S.R. Patanjali, A. Simmons, G.A. Clines, A. Sartiel, R.A. Gatti, L. Chessa, O. Sanal, M.F. Lavin, N.G.J. Jaspers, A.M.R. Taylor, C.F. Arlett, T. Miki, S.M. Weissman, M. Lovett, F.S. Collins, Y. Shiloh, A single ataxia telangiectasia gene with a product similar to PI-3 kinase, Science 268 (1995) 1749-1753.
16. 2 delay in ataxia telangiectasia, Int. J. Radiat. Biol. 47 (1985) 713-722.
17. 2 on X-ray-induced chromosomal aberrations and mitotic inhibition in ataxia telangiectasia fibroblast and lymphoblastoid cells, Hum. Genet. 67 (1984) 329-335.
18. M. Swift, L. Sholman, M. Perry, C. Chase, Malignant neoplasms in the families of patients with ataxia telangiectasia, Cancer Res. 36 (1976) 209-215.
19. M. Swift, P.J. Reitnauer, D. Morrell, C.L. Chase, Breast and other cancers in families with ataxia telangiectasia, N. Eng. J. Med. 316 (1987) 1289-1294.
20. M. Swift, D. Morrell, R.B. Massey, C.L. Chase, Incidence of cancer in 161 families affected by ataxia telangiectasia, N. Eng. J. Med. 325 (1991) 1831-1836.
21. 2 delay and spontaneous chromosome aberrations in ataxia telangiectasia homozygotes and heterozygotes, Int. J. Radiat. Biol. 66 (1994) S157-163.
22. 2 phase X-irradiation, a marker for the ataxia telangiectasia gene, J. Natl. Cancer Inst. 82 (1990) 1050-1054.
23. M. Waghray, S. Al-Sedairy, P.T. Ozand, M.A. Hannan, Cytogenetic characterization of ataxia telangiectasia (AT) heterozygotes using lymphoblastoid cell lines and chronic γ-irradiation, Hum. Genet. 84 (1990) 532-534.
24. 2 chromosomal radiosensitivity in families with ataxia telangiectasia, Hum. Genet. 84 (1989) 8-15.
25. L.A. Jones, D. Scott, R. Cowan, S.A. Roberts, Abnormal radiosensitivity of lymphocytes from breast cancer patients with excessive normal tissue damage after radiotherapy: chromosome aberrations after low dose-rate irradiation, Int. J. Radiat. Biol. 67 (5) (1995) 519-528.
26. D. Scot, L.A. Jones, S.A.G. Elyan, A. Spreadborough, R. Cowan, G. Ribiero, in: R.A. Gatti, R.B. Palmer (Eds.), Identification of AT-heterozygotes in ataxia telangiectasia, NATO ASI Series, 1993, Vol. H77, pp. 101-116.
27. M.N. Cornforth, J.S. Bedford, Ionizing radiation damage and its early development in chromosomes, in: Advances in Radiation Biology, vol. 17, 1993.
28. I. Lopez, G. Tapia, C. Oyarzun, J. Pincheira, Evaluation of chromosome damage induced by X-rays in human lymphocytes, Rev. Med. Chile 121 (1993) 1240-1244.
29. A.T. Natarajan, G. Obe, F.N. Dulout, The effect of caffeine post-treatment on X-ray-induced chromosomal aberrations in human blood lymphocytes in vitro, Hum. Genet. 54 (1980) 183-189.
30. F. Zampetti-Bosseler, D. Scott, The response of normal and ataxia telangiectasia cells to bleomycin: relationships between chromosome damage, cell cycle delay and cell killing, Mutation Res. 151 (1985) 89-94.
31. 2 repair in Down syndrome: effect of caffeine, adenosine and niacinamide in control and X-ray irradiated lymphocytes, Clin. Genet. 45 (1994) 25-31.
32. 2 stage of ataxia telangiectasia cells, Int. J. Radiat. Biol. 66 (3) (1994) 309-317.
33. F. Darroudi, A.T. Natarajan, Cytological characterization of Chinese hamster ovary X-ray-sensitive mutant cells xrs 5 and xrs 6, Mutation Res. 177 (1987) 133-148.
34. 2 phase in a line of normal human fibroblasts and its malignant derivative, J. Natl. Cancer Inst. 69 (1982) 409-414.
35. G. Jimenez, J. Yucel, R. Rowley, S. Subramani, The rad3 + gene of Shizosaccharomyces pombe is involved in multiple checkpoints and in DNA repair, Proc. Natl. Acad. Sci. USA 89 (1992) 4952-4956.
36. V.A. Zakian, ATM-related genes: what do they tell us about functions of the human gene?, Cell 82 (1995) 685-687.
37. M. Swift, Ionizing radiation, breast cancer, and ataxia telangiectasia, J. Natl. Cancer Inst. 86 (21) (1994) 1571-1572.
38. R.A. Eeles, M.R. Stratton, D.E. Goldgar, D.F. Easton, The genetics of familial breast cancer and their practical implications, Eur. J. Cancer 30 (1994) 1383-1390.
39. D.F. Easton, Cancer risks in AT heterozygotes, Int. J. Radiat. Biol. 66 (1994) S177-182.
40. S. Gilad, R. Khosravi, D. Shkedy, T. Uziel, Y. Ziv, K. Savitsky, G. Rotman, S. Smith, L. Chessa, T.J. Jorgensen, R. Harnik, M. Frydman, O. Sanal, S. Portnoi, Z. Goldwicz, N.G.J. Jaspers, R. Gatti, G. Lenoir, M. Lavin, K. Tatsumi, R.D. Wegner, Y. Shiloh, A. Bar-Shira, Predominance of null mutations in ataxia telangiectasia, Human Mol. Genet. 5 (4) (1996) 433-439.
41. M. Telatar, Z. Wang, N. Udar, T. Liang, E. Bernatowska-Matuszkewicz, M. Lavin, Y. Shiloh, P. Concannon, R.A. Good, R.A. Gatti, Ataxia telangiectasia: mutations in ATM cDNA detected by protein truncation screening, Am. J. Human Genet. 59 (1996) 40-44.
42. G. Bebb, K. Gelmon, B. Glickman, R. Gatti, AT risk for breast cancer, Lancet, 21st June, 1997.